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Abstract
As most transcription factors, GATA-1 activities are mediated by interactions with multiple proteins. Those identified so far
associate with the zinc-finger domain and/or surrounding sequences. In contrast, no proteins interacting with the N-terminal domain
have been identified although several evidences suggest its involvement in the control of hematopoiesis. In an attempt to identify
proteins that interact with the N-terminal transactivation domain of GATA-1, a random phage peptide library was screened with
recombinant GATA-1 protein and the sequence of a selected peptide was used for database protein sequence retrieval. We selected a
set of peptides sharing the core sequence /–Bð2–3Þ–mð2–4Þ (where /, B, and m represent hydrophobic, basic, and neutral residues,
respectively). Using the sequence of the most represented peptide (pep5) as query, we retrieved the HIV accessory protein Nef. We
show that Nef binds GATA-1 and GATA-3 in vitro in virtue of its sequence homology with pep5.
 2003 Elsevier Science (USA). All rights reserved.
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GATA-1 is the founder of a family of transcription
factors that bind to the consensus DNA motif (A/T)
GATA (A/G) through a zinc-finger domain highly
conserved among the family members. Several GATA
proteins have been identified in vertebrates (GATA-1–
6) as well as in yeast, fungi, Drosophila melanogaster,
Caenorhabditis elegans, Xenopus leavis, and Arabidopsis
thaliana [1,2]. GATA-1 is expressed in erythroid cells,
megakaryocytes, eosinophils, and mast cells of the he-
matopoietic lineages as well as in Sertoli cells of the
testis [3–9]. Gene targeting loss-of-function studies in
mice have proved that GATA-1 plays an essential role
in normal erythropoiesis and in the maturation of
megakaryocytes [10,11]. Erythroid cell precursors lack-
ing the X-linked GATA-1 gene arrest at the proery-
throblast stage of development and undergo apoptosis
[12].
Like most transcription factors, GATA-1 contains
discrete functional domains. The DNA-binding domain
consists of two C4 zinc-fingers whose roles have been
extensively analyzed either in cell cultures or in vivo
[13,14]. The C-terminal finger is essential for the binding
to the DNA and mediates the regulation of GATA-1
target genes through the interaction with other tran-
scription factors such as Sp1, EKLF, and PU.1 [15–17].
Sequences surrounding the carboxyl terminal finger are
targets of acetylation which stimulates the transcription
activity of GATA-1 [18]. The N-terminal finger influ-
ences the stability and specificity of DNA binding, me-
diates the interaction with the coactivator FOG-1 [19],
and is directly involved in the GATA-1-dependent
maturation of megakaryocytes [20]. The N-terminal re-
gion of GATA-1 (NT) encompasses the first 83 residues
and functions as a transactivation domain in non-he-
matopoietic cells [21–23]. Due to an alternative trans-
lation initiation site usage, the NT domain is missed in a
GATA-1 isoform (GATA-1s) expressed in human and
murine erythroid cells [23]. The role played by the NT
domain in the hematopoietic cell differentiation is still
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debated. Phenotypic rescue studies conducted in G1E
cells, a murine GATA-1-null embryonic stem cell line
expressing the human anti-apoptotic bcl-2 protein [24],
have shown that the NT domain of the mouse GATA-1
is dispensable for terminal erythroid maturation [25]. In
contrast, rescue analyses conducted in vivo show that
the NT domain is required for definitive erythropoiesis
in mice [26]. Moreover, recent studies have shown that
acquired mutations in the GATA-1 gene are associated
with acute megakaryoblastic leukemia in children with
Down syndrome [27]. The mutations prevent the syn-
thesis of the full-length protein but not of the GATA-1s
isoform. These findings suggest that the NT domain is
involved in important, though subtle, cellular mecha-
nisms probably mediating the interaction of GATA-1
with yet unknown cellular partners. Since protein–pro-
tein interactions often occur between discrete motifs that
can be mimicked by simple peptides, we chose to apply
the powerful phage display technology to identify novel
peptides with affinity for GATA-1. By this means sev-
eral biologically relevant peptides have been identified
[28–31] and their analysis has provided insights into the
natural binding partners of target ligands [32].
Screening a linear 9-residue random phage peptide
library against the recombinant N-terminal region of
mouse GATA-1 we identified a set of binding peptides
that share sequence homology. The deduced amino acid
sequence of the most represented selected peptide is
homologous to a sequence within the N-terminal flexible
anchor domain of the HIV/SIV accessory protein Nef
[33,34]. We show that the Nef domain binds GATA-1 in
vitro and that the binding is competed by selected pep-
tides in a dose-dependent manner.
Materials and methods
Recombinant plasmids and Escherichia coli strains. Restriction and
modification enzymes were fromNew England Biolab. To construct the
expression vector pGST–NTGATA-1, the sequence encoding for the
amino-terminal domainof themurineGATA-1 (residues 1–83)wasPCR
amplified from pGDwt [23] using as primers the oligonucleotides NTfor
(50-CGGAATTCATGGATTTTCCTGGTCTAG-30) and NTrev
(50-CGCTCGAGTACTGTTGAGCAGTGGATA-30). The amplified
DNA fragment was restricted with EcoRI and XhoI and inserted into
pGEX-4T1 vector DNA. To construct the expression vector pGST–
Nefð1–35Þ, pLXSN/Nef vector DNA [35], containing the sequence en-
coding for Nef, BRU allele, was restricted with BamHI and XhoI. The
116 bp DNA fragment, encoding for residues 1–35, was inserted into
pGEX4T3. TheEcoRIDNAfragment containing the full-length cDNA
of murine GATA-3 (gift from FrankGrosveld) was cloned in pCDNA3
(Invitrogen) to yield the pGATA-3 construct. Plasmids were routinely
propagated in E. coli cell strain HB101 and DNAs were purified by the
alkali lysismethod (Qiagen). The construct sequenceswere confirmedby
automated DNA sequencing.
Protein expression and affinity resins. GST, GST–NTGATA-1, and
GST–Nefð1–35Þ proteins were expressed in E. coli cells, strain BL21.
Bacteria transformed with pGEX4T1, pGST–NTGATA-1 or pGST–
Nefð1–35Þ, respectively, were grown in 100ml cultures at 37 C in LB
medium (1% Bacto tryptone, 0.5% yeast extract, and 0.5% sodium
chloride) containing 250lg/ml ampicillin. At OD600¼ 0.5, protein ex-
pression was induced for 1 h with 1mM IPTG. Cells were harvested by
centrifugation, suspended in 5ml lysis buffer (PBS containing 1%
Triton X-100, 100mM EDTA, 1mM PMSF, and 5 lg/ml leupeptin),
and disrupted by five sonication pulses. Cell debris were pelleted by
centrifugation and supernatants were incubated with 250ll of packed
G-Sepharose 4B resin (Amersham) for 1 h at room temperature. Resin
slurries were transferred into Poly-prep columns (Bio-Rad) and wa-
shed three times with 5ml PBS. Bound proteins were eluted with 1ml
of 1mM glutathione and extensively dialyzed against PBS. Purified
proteins were checked by SDS–PAGE, quantified by Bradford color-
imetric assay, and bound to new G-Sepharose 4B to yield affinity
resins.
Phage library screening. A phagemid library displaying linear 9-mer
random peptides as fusion products of the M13 phage pVIII capsidic
protein was provided by Dr. F. Felici [36]. The initial diversity of the
library was of 4 107 clones. For each selection and amplification
round, two Poly-prep columns were packed with 200ll GST and
GST–NTGATA-1 affinity resins, respectively, and washed with MPBS
(2% powdered milk in PBS). The phages (5 1010) were adsorbed to
the GST column and the unbound phages were loaded onto the GST–
NTGATA-1 resin. After extensive washes, bound phages were eluted
with 300ll of 100mM triethylamine and neutralized with 150ll of 1M
Tris–HCl, pH 7.4. Eluted phages were titrated and amplified in E. coli
cells, strain TG1, as described [37]. Five rounds of selection and am-
plification were performed.
Colony immunoscreening. To check the enrichment of positive
clones, cells carrying phagemids from each round of selection were
infected with the M13 helper phage K07 to induce phage particle
synthesis as described [37]. About 100CFU was plated onto 2 TY–
agar containing 35 lg/ml IPTG, 50 lg/ml kanamycin, and 250lg/ml
ampicillin and incubated overnight at 37 C. Colonies grown on these
master plates were replicated on nitrocellulose filters. For immuno-
screening, membranes were washed briefly with PBS and incubated for
30 s in 20% acetic acid to inactivate cell phosphatase activities. After
blocking with I-buffer (PBS, 0.1% NP-40, and 5% non-fat dried milk)
for 2 h at 4 C, filters were incubated with 2 lg/ml of soluble GST–
NTGATA-1 protein overnight at 4 C. After extensive washes with W-
buffer (PBS, 0.1% NP-40), filters were probed with a rabbit anti-GST
antibody. The immunocomplexes were revealed by a goat anti-rabbit
IgG conjugated to alkaline phosphatase. Positive clones were picked
from master plates and grown in 3ml of 2 TY containing ampicillin.
Phagemid DNAs were extracted according to standard procedures and
sequenced.
In vitro binding assays. 35S-labelled GATA-1 and GATA-3 proteins
were synthesized in reticulocyte lysates according to the manufacturers
instructions (Promega). Briefly, 250 ng pGDwt or pGATA-3 DNA was
transcribed and translated in 12.5ll volume reactions containing
10 lCi [35S]methionine and T7 RNA polymerase. Reactions were in-
cubated for 90min at 30 C and used immediately or frozen at )80 C.
For binding assays, 1.5 105 TCA-precipitable cpm of labelled protein
was mixed with 18 lg GST or 21lg GST–Nefð1–35Þ resins (same molar
equivalent) in 150ll of binding buffer (25mM Hepes, 150mM NaCl,
and 0.5% Triton X-100, pH 7.2). After 2 h at 4 C, resins were trans-
ferred into microspin columns (Bio-Rad) and centrifuged briefly.
Resins were washed four times with binding buffer and the bound
proteins were eluted with 30 ll Laemmlis buffer and loaded onto a
10% SDS–PAGE. The gel was fixed in 1M salicylic acid for 1 h, dried,
and exposed overnight. For competition assays, the peptides pepNef
(RMRRAEPAA), pep5 (RMRRSNPTL), and pep5-mut (EM-
DASNPTL) were synthesized (R&D). Peptides were reconstituted in
binding buffer and the protein concentration was determined. TCA-
precipitable cpm (104) of GATA-1 or GATA-3 was mixed with 425lg
GST–Nefð1–35Þ resins in 160ll of binding buffer. The larger amount of
resin used in the competition with respect to the binding assay was to
ensure the quantitative binding of labelled proteins. The binding was
challenged with 10- or 100-fold molar excess of each peptide. The
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bound complexes were analyzed by SDS–PAGE and fluorography as
described.
Results
Identification of peptides binding to the N-terminal
domain of the mouse GATA-1
To identify peptides that bind to the N-terminal do-
main of GATA-1, we screened a phage library display-
ing random linear 9-residue peptides by affinity
chromatography. The N-terminal domain of the mouse
GATA-1 (NTGATA-1) was bacterially expressed as a
fusion product of the glutathione S-transferase (GST–
NTGATA-1) and affinity purified onto G-Sepharose
resin. The GST–NTGATA-1 affinity resin was prepared
as described in Materials and methods and used for
phage library screening. To subtract for phage-displayed
peptides with affinity for the GST protein moiety, the
input phages were absorbed onto a GST–Sepharose re-
sin at each round of selection/amplification. Five rounds
of selection/amplification were carried out and the en-
richment of clones binding to NTGATA-1 was assessed
by colony immunoscreening. E. coli cells infected with
the phagemids eluted from the GST–NTGATA-1 resin
were superinfected with the M13 helper phage K07 and
plated on agar. Colonies were replicated onto nitrocel-
lulose filters and probed with soluble GST–NTGATA-1
protein. Positive clones were revealed by immunostain-
ing using anti-GST antibodies. As much as 10% and
90% positive clones were obtained from the fourth and
fifth rounds, respectively (Fig. 1).
Sequences of peptides binding to NTGATA-1 and genomic
database search
The DNA inserts of 20 individual positive clones
from the fifth round of selection/amplification were an-
alyzed and their deduced peptide sequences are shown in
Table 1. The alignment of peptide sequences reveals that
they share the core motif /–Bð2–3Þ–mð2–4Þ, where /, B, and
m represent hydrophobic, basic, and neutral residues,
respectively. The pep5 sequence, the most represented
peptide binding to NTGATA-1, was used to search ge-
nomic databases for proteins containing sequence ho-
mology. All non-redundant coding sequences available
at the GenBank database were searched with the pro-
gram BLASTP [38]. The first 43 sequences scored by
homology degree corresponded to the Nef protein, an
accessory viral protein expressed by the HIV-1, HIV-2,
and SIV viruses. The homology spans residues 19–26 of
the amino-terminal region of Nef and ranges from 75%
to 87% depending on Nef alleles (Fig. 2).
Fig. 1. Immunodetection of phage-displayed peptides that bind
NTGATA-1. The expressing phagemids (ffi100CFU) eluted from the
fourth (A) and fifth (B) rounds of selection were replicated onto ni-
trocellulose filters and probed with soluble GST–NTGATA-1. Protein
complexes was detected with rabbit anti-GST serum and immuno-
stained with a secondary antibody conjugated to alkaline phosphatase.
Table 1
9-mer peptides binding NTGATA-1
Name of phage
clones
Peptide sequences Number of
time selected
pep1 L R T R K S S L S 4
pep2 G L R Q R K F S S 1
pep3 L M H R R T N P P 2
pep4 A N Y R R P Q A V 1
pep5 R M R R S N P T L 5
pep6 Y R A H R A R A V 1
pep7 L R A K R T S I T 1
pep8 Y R L I K R N S P 1
pep9 R L R R H Q L V L 1
pep10 Y K R H S P H A P 1
pep11 Y K R R I V E P L 1
pep12 Y K R H E A R I V 1
Core motifa / Bð2–3Þ mð2–4Þ
a/, B, and m represent hydrophobic, basic, and neutral residues,
respectively.
Fig. 2. Sequence of the Nef protein. The sequence of the Nef protein,
BRU allele, is shown. The homology with pep5 is underlined.
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The amino-terminal domain of Nef binds GATA-1 in vitro
Nef is a protein encoded by primate immunodefi-
ciency viruses [39]. Although Nef is important in the
pathogenesis of lentiviruses (reviewed in [40]), the mo-
lecular mechanisms underlying its functions are partly
understood. Nef structure consists of two domains: a N-
terminal flexible membrane anchor domain (residues
1–57) and a well-folded major core domain (residues 58–
206). The core domain contains several sequence motifs
that mediate the interaction of Nef with proteins in-
volved in cellular signalling or trafficking pathways
(reviewed in [41]). The N-terminal domain contains the
sequence for myristoylation that mediates the mem-
brane anchoring of the protein [42]. More recently, it
has been shown that Nef binds p53 via its N-terminal
domain and protects cells against p53-mediated apop-
tosis [43]. Since the Nef amino-terminal domain includes
the sequence homologous to pep5, we decided to verify
whether this domain binds to GATA-1. The sequence
encompassing residues 1–35 of Nef, allele BRU, was
expressed in bacteria as a GST fusion protein (GST–
Nefð1–35Þ) and used to prepare an affinity resin suitable
for in vitro binding assays. As shown in Fig. 3, 35S-la-
belled GATA-1 is specifically bound by the GST–
Nefð1–35Þ affinity resin.
Synthetic peptides compete for GST- Nef(1–35) binding to
GATA-1
To assess whether Nefð1–35Þ binds to GATA-1 through
the residues homologous to pep5, we performed in vitro
competition assays. We synthesized the nonapeptides
RMRRSNPTL, corresponding to the peptide pep5, the
mutant EMDASNPTL (pep5-mut), and RMRRAE-
PAA (pepNef), corresponding to the Nef residues 19–27
of the BRU allele product. The binding of GST–Nefð1–35Þ
to 35S-labelled GATA-1 was challenged with 10- or 100-
fold molar excess of each peptide and the bound GATA-
1 was analyzed by SDS–PAGE. As shown in Fig. 4,
either pep5 or pepNef efficiently competes for GATA-1
binding while the mutant peptide does not. This result
indicates that the Nefð1–35Þ/GATA-1 interaction is spe-
cific and involves the arginine residues 19, 21, and 22 of
the Nef N-terminal flexible anchor domain.
The N-terminal flexible anchor domain of Nef binds
another GATA member in vitro
Nef plays key functions in the HIV-1 infection of T
lymphocytes. In these cells GATA-3 is the predomi-
nantly expressed GATA factor. As all GATA members,
the sequence homology between GATA-1 and GATA-3
is restricted to the zinc-finger domain. However, the
transactivation domain of GATA-3 resides within the
N-terminal region of the protein [44]. Thus, we decided
to verify whether Nefð1–35Þ binds GATA-3 as well in vi-
tro. As shown in Fig. 5, GST–Nefð1–35Þ binds GATA-3
and the binding is competed by peptides pep5 or pepNef
while it is not by the mutant peptide pep5-mut.
Discussion
GATA-1 is a zinc-finger transcription factor that
plays a pivotal role in erythroid and megakaryocytic cell
maturation. A growing body of evidence indicates that
GATA-1 activities are mediated by the assembling of
multiprotein complexes on discrete GATA-1 functional
domains. To date, several proteins have been identified
on the basis of their ability to interact physically with
the two zinc-finger domains of GATA-1 ([45] and ref-
erences therein). In contrast, very little is known about
the proteins that interact with other GATA-1 domains.
Fig. 3. The N-terminal domain of Nef binds GATA-1 in vitro. In vitro
translated (IVT) 35S-labelled GATA-1 or luciferase was mixed (I) and
loaded onto GST or GST–Nefð1–35Þ resins. Unbound (U) and bound
(B) proteins were analyzed by SDS–PAGE and fluorography.
Fig. 4. The binding of the N-terminal domain of Nef to GATA-1 is
competed by peptides pep5 and pepNef. In vitro translated 35S-labelled
GATA-1 (Input) was loaded onto the GST resin (GST) or the GST–
Nefð1–35Þ resin and the binding was unchallenged (no peptide) or
challenged with a 10- (10) or 100-fold (100) molar excess of the
indicated competitor peptides. Bound protein was analyzed by SDS–
PAGE and fluorography.
Fig. 5. The N-terminal domain of Nef binds GATA-3. In vitro
translated 35S-labelled GATA-3 (Input) was loaded onto the GST resin
(GST) or the GST–Nefð1–35Þ resin and the binding was unchallenged
(no peptide) or challenged with a 10- (10) or 100-fold (100) molar
excess of the indicated competitor peptides. Bound protein was ana-
lyzed by SDS–PAGE and fluorography.
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In particular, no cellular partners have been yet identi-
fied to bind the N-terminal domain of GATA-1, though
several experimental and genetic data strongly suggest
its involvement in important processes. In this regard,
the studies have been mainly hampered by the impos-
sibility to count on conventional methods for screening.
For instance, the yeast two-hybrid system, the leading
method used to identify interacting partners, is not
applicable to the GATA-1 N-terminal domain since
it efficiently transactivates yeast gene promoters
(unpublished data). As described here, we have taken an
alternative approach to identify proteins potentially
capable of interacting with GATA-1. Screening a phage
random peptide library, we have identified a set of
phages that bind the N-terminal transactivation domain
of GATA-1 (residues 1–83). The phage-displayed pep-
tides share the sequence core motif /–Bð2–3Þ–mð2–4Þ (where
/, B, and m represent hydrophobic, basic, and neutral
residues, respectively) which mediates the physical in-
teraction with GATA-1 as proved by competition
binding assays. Searching databases for proteins con-
taining sequence homology to the most represented
peptide (pep5), we retrieved the HIV accessory protein
Nef. The homology spans residues 19–26 of the amino-
terminal domain (numeration referred to the BRU allele
product) and ranges from 75% to 87% depending on Nef
alleles. We show that in virtue of this homology the
amino-terminal domain of Nef binds GATA-1 and
GATA-3 in vitro. The competition data indicate that the
interaction is mediated by the Nef residues R19, R21,
and R22. These data, together with the recent finding
showing that the same sequence is involved in the
physical association with the tumor-suppressor protein
p53 [43], suggest that Nef may act as a nuclear regula-
tory factor.
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